中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2015年
9期
101-102
,共2页
美多巴%早期非创伤性股骨头坏死%骨密度%联合治疗
美多巴%早期非創傷性股骨頭壞死%骨密度%聯閤治療
미다파%조기비창상성고골두배사%골밀도%연합치료
madopar%early non-traumatic femoral head onecrosis%bone mineral density%combined therapy
目的:探讨美多巴与多种药物联合治疗早期非创伤性股骨头坏死患者骨密度的临床效果。方法将2013年3月至2014年3月收治的56例非创伤性股骨头坏死患者作为研究对象,所有患者通过美多巴和抗凝药、双膦酸盐及中药联合治疗,并在治疗前后接受双髋前后位的磁共振成像和X线摄片检查,统计患者的检查结果。结果 X线摄片检查早期非创伤性股骨头坏死患者治疗后股骨头的骨密度较治疗前明显增大;治疗后的坏死指数为(49.54±30.08)分,比治疗前下降显著( P<0.05);塌陷率为30.09%;临床改善率61.53%;治疗成功率69.45%;治疗后患者Merle D'Aubigne评分总分(16.21±2.32)分,显著高于治疗前的(13.16±2.71)分( P<0.05)。结论美多巴联合抗凝药、双膦酸盐及中药治疗早期股骨头坏死患者的临床效果十分明显,可以促进骨形成,加速骨愈合修复,降低股骨头塌陷率。
目的:探討美多巴與多種藥物聯閤治療早期非創傷性股骨頭壞死患者骨密度的臨床效果。方法將2013年3月至2014年3月收治的56例非創傷性股骨頭壞死患者作為研究對象,所有患者通過美多巴和抗凝藥、雙膦痠鹽及中藥聯閤治療,併在治療前後接受雙髖前後位的磁共振成像和X線攝片檢查,統計患者的檢查結果。結果 X線攝片檢查早期非創傷性股骨頭壞死患者治療後股骨頭的骨密度較治療前明顯增大;治療後的壞死指數為(49.54±30.08)分,比治療前下降顯著( P<0.05);塌陷率為30.09%;臨床改善率61.53%;治療成功率69.45%;治療後患者Merle D'Aubigne評分總分(16.21±2.32)分,顯著高于治療前的(13.16±2.71)分( P<0.05)。結論美多巴聯閤抗凝藥、雙膦痠鹽及中藥治療早期股骨頭壞死患者的臨床效果十分明顯,可以促進骨形成,加速骨愈閤脩複,降低股骨頭塌陷率。
목적:탐토미다파여다충약물연합치료조기비창상성고골두배사환자골밀도적림상효과。방법장2013년3월지2014년3월수치적56례비창상성고골두배사환자작위연구대상,소유환자통과미다파화항응약、쌍련산염급중약연합치료,병재치료전후접수쌍관전후위적자공진성상화X선섭편검사,통계환자적검사결과。결과 X선섭편검사조기비창상성고골두배사환자치료후고골두적골밀도교치료전명현증대;치료후적배사지수위(49.54±30.08)분,비치료전하강현저( P<0.05);탑함솔위30.09%;림상개선솔61.53%;치료성공솔69.45%;치료후환자Merle D'Aubigne평분총분(16.21±2.32)분,현저고우치료전적(13.16±2.71)분( P<0.05)。결론미다파연합항응약、쌍련산염급중약치료조기고골두배사환자적림상효과십분명현,가이촉진골형성,가속골유합수복,강저고골두탑함솔。
Objective To explore the clinical effect of madopar combined with multiple drugs on the bone mineral density ( BMD ) for treating early non-traumatic femoral head necrosis. Methods Totally 56 patients with early non-traumatic femoral head necrosis in our hospital from March 2013 to March 2014 were chosen as the research subjects and performed the combined therapy of oral madopar anticoagulation, diphosphonate and traditional Chinese medicines. And the magnetic resonance imaging ( MRI ) and plain radio-graphs were conducted before and after treatment. All examination results were collected and analyzed for evaluating the clinical treat-ment effect by scores. Results BMD of femoral head after treatment was significantly increased compared with before treatment, the necrosis index after treatment was ( 49. 54 ± 30. 08 ) , which was significantly decreased compared with before treatment( P < 0. 05);the collapse rate was 30. 09%, the clinical improvement rate was 61. 53% and the treatment success rate was 69. 54%, the Merle D’Aubigne scores after treatment reached ( 16. 21 ± 2. 32 ) points, which was significantly higher than ( 13. 16 ± 2. 71 ) points before treatment, which fully indicated that this combined therapy effectively improved the lesion symptoms, relieved the disease condition and the difference was statistically significant ( P < 0. 05 ) . Conclusion Madopar combined with multiple drugs for treating early non-traumatic femoral head necrosis has very obvious effect, can promote the bone formation, accelerate the repair of bone healing, reduce the femoral head collapse rate and is worthy of being clinically popularized and applied.